At the annual meeting of the American Diabetes Association meeting last week, a diabetes epidemiologist compares and contrasts competing CGMs both based on features and accuracy.
The world of data-driven diabetes care has been blown open in the last couple of years with advances in continuous glucose monitoring, digital health and, for Type 1 diabetics, the arrival of the "artificial pancreas."
Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando.
Continuous glucose monitoring has not been around a long time, but it appears that some who use it, swear by it.
In a long-awaited deal, Bayer has sold its diabetes unit to Panasonic for $1.13 billion, thanks to growing competition from next-gen diabetes monitors.